OnabotulinumtoxinA for Trigeminal Neuralgia
ConditionTrigeminal Neuralgia
Trial statusRecruiting
Trial phasePhase 4
Trial typeInterventional
Biological sexAll
Age18+
SponsorStanford University
About this trial
A randomized controlled trial comparing Onabotulinumtoxin A to saline (placebo) for Trigeminal Neuralgia.
Eligibility criteria
Qualifiers
Judged to be of legal competence
Sufficient knowledge of written and spoken English
Capable of attending regular in-person visits
Have failed/not a candidate/do not want surgery
Disqualifiers
Secondary or Idiopathic TN, or Painful Trigeminal Neuropathy as defined by the ICHD (13.1.1.2, 13.1.1.3, 13.1.2)
Pregnant or breast feeding (while it is rare that a patient will be pregnant with TN, there is not sufficient data to say definitively that onabotA is ok to use during pregnancy and nursing, it is still rated Class C)
Neuromuscular disease
On aminoglyocosides
Trial design
Treatments tested in this trial
- OnabotulinumtoxinA 100 UNT [Botox]
- Sodium Chloride 0.9% for Injection, Preservative Free
Treatment groups
20 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov